GLAXO: Vacunas...a pesar de todo.

Amid the furore caused by claims from Europe about a fake pandemic and governments renegotiating their contracts, GlaxoSmithKline has revealed that sales of its influenza A (H1N1) vaccine reached £835 million (950 mio€) in the fourth quarter.

The drugs giant says that around 130 million doses of its swine flu vaccine were delivered to governments in the fourth quarter of 2009. These shipments, along with pandemic vaccine products supplied to the USA and other governments in the quarter, amounted to unaudited sales sales of £835 million. GSK also noted that a donation of 60 million vaccine doses to the World Health Organisation will be charged as a selling, general and administrative cost in the fourth quarter of 2009.

The company added that shipments of the vaccine continue to be delivered in the first half of 2010 and it is in “ongoing discussions with many governments, as their needs evolve”. This includes renegotiation of contracts, as well as with governments who have placed new orders for the vaccine, and it is “therefore too early to say what the final number of doses supplied and the value of these orders will be”.

Más...